Pharma Reviews: Will pharma regulator's deal with industry make non-price control drugs cheaper?

Non-scheduled drugs, or formulations outside price control, account for Rs 10,000 crore of sales in the Rs 1-lakh-crore Indian drug market, the report ...
Read more: Will pharma regulator's deal with industry make non-price control drugs cheaper?